Leonteq Securities’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Leonteq Securities's LFCR Position: Q3 2026 in Review
Leonteq Securities held its Lifecore Biomedical (LFCR) position steady in Q3 2026 at 26 shares worth $171. The position accounts for ﹤0.01% of the portfolio, ranked #1259.
Leonteq Securities first reported a position in LFCR in Q2 2022 and has held it in 18 quarters since. The position peaked at $259 in Q2 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Leonteq Securities held 26 shares of Lifecore Biomedical worth $171 as of Q3 2026.
- Leonteq Securities left its Lifecore Biomedical share count unchanged in Q3 2026.
- Lifecore Biomedical made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1259 holding.
- Leonteq Securities first reported a position in Lifecore Biomedical in Q2 2022 and has held it in 18 quarters since.
- Leonteq Securities's Lifecore Biomedical position peaked at $259 in Q2 2022.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.